• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2000816 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2020-06-12 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-19 view
JYHZ2000026 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-03-11 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JYHZ2000027 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-02-25 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JYSB2000001 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-02-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-08-31 view
JYSB2000002 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-02-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-08-31 view
JYSB1900366 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-01-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-01-08 view
JYSB1900367 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-01-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-01-08 view
JYSB1900204 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2019-09-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-05 view
JYSB1900205 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2019-09-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-05 view
JYSB1800118 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYSB1800119 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYSB1800095 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-09-19 view
JYSB1800099 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-09-19 view
JYSB1800098 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view
JYSB1800096 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view
JYSB1800002 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-01-26 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-08-05 view
JYSB1800001 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-01-26 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-08-05 view
JYSB1700169 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYSB1700170 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYHZ1700051 替米沙坦氢氯噻嗪片 hydrochlorothiazide;telmisartan Tablet Chemical Drugs License Renew 2017-08-24 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2017-10-19 view